CLERKSHIP 12Q1326

SNO CLERKSHIP ACTIVITIES NO. OF CASES I Therapeutic intervention 2 II Suspected adverse drug reactions III Drug interaction 8 IV Patient Counselling V Drug Information 3 VI Disease Counselling VII Treatment chart review 1 VIII Patient medication history interview IX Seminars and Assignments TOTAL 25

Therapeutic intervention Done therapeutic intervention on tuberculosis IP.NO. 4418 Done therapeutic intervention on malaria IP.NO. 4936 Suspected adverse drug reactions 1.Suspected adverse reaction on injection amikacin Description of event: Skin rash,esinophylia Causality Assessment : Doubtful Severity Assessment Scale : Mild 2.Suspected adverse reaction on tablet Azee Description of the event: Diarrhea,fever,headache

1.Drug interactions in COPD IP.NO. 40372 Theophylline + Rabeprazole Using theophylline with rabeprazole may increase the effects of theophylline. Dose adjustment should needed. 2. Drug interactions in acute exacerbation of Bronchial Asthma Ondansetron + Magnesium Hydroxide IPNo. 49812 Using together can cause irregular heart rhythm. Do not exceed normal dose. should need dose adjustment.

3. Drug interactions in COPD IP.NO. 1578 Theophylline +Hydrocortisone Using together may cause hypokalemia and also increases levels of theophylline. Need dose adjustment. Theophylline + Pantoprazole Using together can increases the levels of theophylline. Need dose adjustment. 4. Drug interaction in Chronic Bronchitis IP.NO. 2345 Tobramycin + Cefoperazone Some times it will cause kidney damage.It may increase that risk. Monitor closely

Using together will cause hypomagnesemia. Need dose adjustment. Tobramycin + Pantoprazole Using together will cause hypomagnesemia. Need dose adjustment. Theophylline + Pantoprazole Using together can increases the levels of theophylline. Need dose adjustment 5. Drug Interaction in Chronic bronchitis IP.NO. 5087 Ondansetron+ Levofloxacin Using levofloxacin together with ondansetron can increase the risk of irregular heart rhythm. 6. Drug Interactions in Acute Bronchitis IP.NO. 5326 Hydrocortisone +Terbutaline Its a minor interaction. Need dose Adjustment.

7. Drug Interactions in Acute coronary syndrome with COPD Atorvastatin+Clopidogrel IP.NO. 42292 This combination may reduce effects of clopidogrel. Need dose adjustment. Asprin + Clopidogrel This may cause severe side effects like bleeding and abdominal pain. 8. Drug interactions in Bronchial Asthma. IP.NO. 751 Theophylline + Rabeprazole Using theophylline with rabeprazole may increase the effects of theophylline. Dose adjustment should needed.

Patient Counselling 1. Patient Counselling done on Chronic Asthma with Acute Exacerbation: IP.NO. 38426 Life Style Modifications Do not expose to allergens. Cover nose with kerchief or wear face mask if it is cold outside. Exercise regularly to strengthen your heart and lungs. Maintain healthy weight.being over weight can worsen asthma symptoms. Use air conditioner.It will lower indoor humidity Do not expose to mites , dust

2.Patient counselling done on COPD: IP.NO. 40426 Take oxygen inhalation. Do not expose to allergens. Cover nose with kerchief or wear face mask if it is cold outside. Exercise regularly to strengthen your heart and lungs. Maintain healthy weight.being over weight can worsen asthma symptoms. Use air conditioner.It will lower indoor humidity Do not expose to mites , dust Cessation of smoking .

Drug Information 1.Provided drug information on Levofloxacin. Trade name: Injection Levoflox Class: Fluoroquinolones Dose:500 mg/100ml Uses:Respiratory tract infections, cellulities, UTI, meningities, TB,Endocardities MOA: It inhibits the enzyme bacterial DNA gyrase and prevents replication of bacterial DNA during bacterial growth and reproduction. Adverse Effects:headache,dizziness, Gastric pain,constipation,insomnia,itching,redness,swelling of skin.

2. Provided drug information on Tablet. lubiprostone Trade name:Tablet 2. Provided drug information on Tablet. lubiprostone Trade name:Tablet. lubiprostone Class: IBS Agents, Laxative Dose: 24mcg, 8mcg Uses:IBS,Constipation MOA: It is a bicyclic fattyacid .Locally acting chloride channel activator,increases intestinal fluid secretion and intestinal motility. Adverse Effects: edema , abdominal distress, dizziness, dispepsia , abdominal pain, loss of consciousness

3. Provided drug information on Linezolid Trade Name: Injection 3.Provided drug information on Linezolid Trade Name: Injection .Lizoforce Class: Oxazolidinones Dose: 2mg/ml (100ml,300ml) ROA: Oral , I.V Tablet: 600mg Uses: Skin infections,Community acquired pneumonia,Resistant staphylococcal infections, lung infections MOA: Binds to bacterial 23S RNA of the 50S subunit to prevent protein translation .Also elicits non selective mono amino oxidase inhibition. Inhibits bacterial protein synthesis. Adverse Effects: generalized abdominal pain, In pediatrics thrombocytopenia, loose stools, anemia, eosinophilia.

Disease Counselling 1.Counselling done on Chronic Asthma with Acute Exacerbation IP.NO. 38426 Maintain normal pulmonary function. Prevent chronic and troublesome symptoms. Prevent recurrent exacerbations of asthma and minimize the need for emergency department visits. Provide optimal pharmacotherapy with minimal or no adrs. 2.Counselling done on COPD IP.NO. 40426 Prevent recurrent exacerbations of copd and minimize the need for emergency department visits. Inhalers should be taken as prescribed by the doctor.

Treatment chat review For Acute Exacerbation of Chronic Asthma IP.NO. 40006 s.n.o Trade Name Generic name Dose 1 2 3 4 5 T.Dolo 1-1-1 Acetaminophen 650mg y I.Amikacin Amikacin 500mg n Budecort Neb Budesonide 6hrly I.Aciloc 1-1-1 Ranitidine 50mg T.Mucinac1-1-1 Acetylcysteine 600mg 6 I.Effcorlin 1-1-1 Hydrocortisone 100mg 7 T.Zofer 1-0-0 Ondansetron 4mg 8 Liq.Asthalin1-1-1 Salbutamol 5ml 9 T.Zoton 1-0-0 Lansoprazole 30mg

Patient Medication History 1.Patient Name: sushilabai IP .NO. 40513 Age: 60yrs Patient is not having any social history,medical,medication history Patient is diagnosed with Chronic Liver Disease Patient was found to be low adhered to the medication 2. Patient Name: sangamma IP.NO. 4678 Age: 65yrs Past Medical History: COPD since 10 yrs Patient diagnosed with Acute Exacerbation of COPD with type-2 DM

Seminars And Assignments 3. Patient Name : Malasiddappa IP.NO. 4968 Age : 55yrs Past Medical History: COPD Patient diagnosed with Acute Exacerbation of COPD Patient was found to be low adhered to the medication Seminars And Assignments 1. Difference between Type-I and Type-II DM 2. Give standard drug therapy for Asthma and COPD 3. Co-relation between persistant cough and blood pressure.